Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 4831 AL 4845

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism

Lindholm P, Saarma M.

Mol Psychiatry. 2022 Mar;27(3):1310-1321. doi: 10.1038/s41380-021-01394-6. Epub 2021 Dec 14.

Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta-analysis

Lu S, Jiang HY, Shi YD.

Acta Neurol Scand. 2022 Apr;145(4):442-448. doi: 10.1111/ane.13570. Epub 2021 Dec 15.

Dopamine transporter (DAT) imaging in Parkinson's disease and related disorders

Brücke T, Brücke C.

J Neural Transm (Vienna). 2022 Jun;129(5-6):581-594. doi: 10.1007/s00702-021-02452-7. Epub 2021 Dec 15.

Benefits of aquatic exercise in adults with and without chronic disease-A systematic review with meta-analysis

Faíl LB, Marinho DA, Marques EA, Costa MJ, Santos CC, Marques MC, Izquierdo M, Neiva HP.

Scand J Med Sci Sports. 2022 Mar;32(3):465-486. doi: 10.1111/sms.14112. Epub 2021 Dec 24.

[Sleep disorders in patients with a neurocognitive disorder]

Moderie C, Carrier J, Dang-Vu TT.

Encephale. 2022 Jun;48(3):325-334. doi: 10.1016/j.encep.2021.08.014. Epub 2021 Dec 14.

GOCOVRI(®) (amantadine) extended-release capsules in Parkinson's disease

Müller T.

Neurodegener Dis Manag. 2022 Feb;12(1):15-28. doi: 10.2217/nmt-2021-0028. Epub 2021 Dec 17.

Targeting disorders in unstructured and structured proteins in various diseases

Choudhary S, Lopus M, Hosur RV.

Biophys Chem. 2022 Feb;281:106742. doi: 10.1016/j.bpc.2021.106742. Epub 2021 Dec 11.

WATSU therapy for individuals with Parkinson's disease to improve quality of sleep and quality of life: A randomized controlled study

Loureiro APC, Burkot J, Oliveira J, Barbosa JM.

Complement Ther Clin Pract. 2022 Feb;46:101523. doi: 10.1016/j.ctcp.2021.101523. Epub 2021 Dec 15.

Clinical milestones in Parkinson's disease: Past, present, and future

Marsili L, Mahajan A.

J Neurol Sci. 2022 Jan 15;432:120082. doi: 10.1016/j.jns.2021.120082. Epub 2021 Dec 14.

Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis

Gadhe L, Sakunthala A, Mukherjee S, Gahlot N, Bera R, Sawner AS, Kadu P, Maji SK.

Biophys Chem. 2022 Feb;281:106736. doi: 10.1016/j.bpc.2021.106736. Epub 2021 Dec 6.

Wilful pathogens provoke a gut feeling in Parkinson's disease

Sian-Hülsmann J.

J Neural Transm (Vienna). 2022 Jun;129(5-6):557-562. doi: 10.1007/s00702-021-02448-3. Epub 2021 Dec 19.

Manganese transport in mammals by zinc transporter family proteins, ZNT and ZIP

Fujishiro H, Kambe T.

J Pharmacol Sci. 2022 Jan;148(1):125-133. doi: 10.1016/j.jphs.2021.10.011. Epub 2021 Nov 2.

Nephrotic Syndrome and Atypical Posterior Reversible Encephalopathy Syndrome in a Patient with Parkinson's Disease

Tokimura R, Ito E, Sugiura Y, Ugawa Y.

Intern Med. 2022 Jul 1;61(13):2061-2065. doi: 10.2169/internalmedicine.8746-21. Epub 2021 Dec 18.

[The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients]

Tezuka T, Osada T, Terayama Y, Kubota M, Okusa S, Shiihashi G, Kubo SI, Suzuki N, Nakahara J, Seki M.

Rinsho Shinkeigaku. 2022 Jan 28;62(1):8-14. doi: 10.5692/clinicalneurol.cn-001663. Epub 2021 Dec 18.

Parkinson disease: Protective role and function of neuropeptides

Tabikh M, Chahla C, Okdeh N, Kovacic H, Sabatier JM, Fajloun Z.

Peptides. 2022 May;151:170713. doi: 10.1016/j.peptides.2021.170713. Epub 2021 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias